Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
SKYX Reports Increase of 15% with Record Second Quarter 2025 Revenues of $23.1 Million Compared to $20.1 Million for First Quarter 2025 as it Continues to Grow its Market Penetration in the U.S. and C
-
OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update
-
Mineralys Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Beyond Air® Reports Fiscal First Quarter 2026 Financial Results and Provides Corporate Update
-
Anterix Inc. Reports First Quarter Fiscal Year 2026 Results
-
High Roller Reports Q2 2025 Results
-
NEXGEL Reports Second Quarter 2025 Financial Results
-
BioRestorative Therapies Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Fold Holdings, Inc. (NASDAQ: FLD) Announces Second Quarter 2025 Results
-
Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Generation Bio Announces New Data for Its Novel ctLNP Delivery System and Early T Cell Programs and Reports Second Quarter 2025 Financial Results
-
Metagenomi Reports Business Updates and Second Quarter 2025 Financial Results
-
Inspirato Reports Q2 Financial and Operating Results
-
WEBTOON Entertainment Inc. Reports Second Quarter 2025 Financial Results
-
Annovis Provides Corporate Updates and Reports Second Quarter 2025 Financial Results
-
Mobile Infrastructure Reports Second Quarter 2025 Financial Results
-
Iridex Reports Second Quarter 2025 Financial Results
-
Alico, Inc. Announces Financial Results for the Third Quarter Ended June 30, 2025
-
Slide Reports Second Quarter 2025 Results
-
Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
-
DeFi Development Corp. Announces Second Quarter 2025 Earnings
-
Varonis to Present at Upcoming Investor Conference
-
Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025
-
ORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational Updates
-
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results
-
Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
-
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
-
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
-
Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights
-
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
-
FormFactor, Inc. Announces CFO Transition
-
IZEA Reports Q2 2025 Revenue of $9.1 Million
-
Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update
-
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
-
Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Compass Therapeutics Announces Proposed Public Offering
-
Erasca Reports Second Quarter 2025 Business Updates and Financial Results
-
Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates
-
374Water Reports Second Quarter 2025 Financial Results
-
Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results
-
Editas Medicine Announces Second Quarter 2025 Results and Business Updates
-
Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year
-
Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease
-
Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock
-
Spectral AI Announces 2025 Second Quarter Financial Results
-
Pest Control Expert Brittany Thacker Explains Fall Bug Surges in HelloNation Magazine
